4578 N Stock Overview

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. More details

4578 N fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	1/6
Past Performance	1/6
Financial Health	6/6
Dividends	3/6

Rewards

Earnings are forecast to grow 10% per year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

My Notes

Capture your thoughts, links and company narrative

Otsuka Holdings Co., Ltd. Competitors

Genomma Lab Internacional. de

BMV:LAB B

Mex$25.4b

Takeda Pharmaceutical

TSE:4502

JP¥6.4t

Zhangzhou Pientzehuang Pharmaceutical

SHSE:600436

CN¥122.8b

Astellas Pharma

TSE:4503

JP¥2.7t

Price History & Performance

Summary of share price highs, lows and changes for Otsuka Holdings
Historical stock prices
Current Share Price	JP¥1,140.37
52 Week High	JP¥1,247.81
52 Week Low	JP¥761.11
Beta	0.21
1 Month Change	0%
3 Month Change	-8.61%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	49.83%

Recent updates

Shareholder Returns

	4578 N	MX Pharmaceuticals	MX Market
7D	0%	2.9%	0.5%
1Y	n/a	-19.5%	-9.4%

Return vs Industry: Insufficient data to determine how 4578 N performed against the MX Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 4578 N performed against the MX Market.

Price Volatility

Is 4578 N's price volatile compared to industry and market?
4578 N volatility
4578 N Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	5.9%
Market Average Movement	4.0%
10% most volatile stocks in MX Market	7.0%
10% least volatile stocks in MX Market	2.7%

Stable Share Price: 4578 N's share price has been volatile over the past 3 months compared to the MX market.

Volatility Over Time: Insufficient data to determine 4578 N's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1921	34,388	Makoto Inoue	www.otsuka.com

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement instruments, nutritional products, vehicle headlight testers, synthetic resin molded products, paper products, and insecticide and toiletry products.

Otsuka Holdings Co., Ltd. Fundamentals Summary

How do Otsuka Holdings's earnings and revenue compare to its market cap?
4578 N fundamental statistics
Market cap	Mex$571.26b
Earnings (TTM)	Mex$20.11b
Revenue (TTM)	Mex$301.14b

28.4x

P/E Ratio

1.9x

P/S Ratio

Is 4578 N overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4578 N income statement (TTM)
Revenue	JP¥2.27t
Cost of Revenue	JP¥648.61b
Gross Profit	JP¥1.62t
Other Expenses	JP¥1.47t
Earnings	JP¥151.58b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 14, 2025

Earnings per share (EPS)	282.21
Gross Margin	71.42%
Net Profit Margin	6.68%
Debt/Equity Ratio	10.1%

How did 4578 N perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

43%

Payout Ratio

Does 4578 N pay a reliable dividends?

See 4578 N dividend history and benchmarks

When do you need to buy 4578 N by to receive an upcoming dividend?
Otsuka Holdings dividend dates
Ex Dividend Date	Dec 27 2024
Dividend Pay Date	Mar 31 2025
Days until Ex dividend	27 days
Days until Dividend pay date	67 days

Does 4578 N pay a reliable dividends?

See 4578 N dividend history and benchmarks

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/22 21:36
End of Day Share Price	2024/12/17 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Otsuka Holdings Co., Ltd. is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Atsushi Seki	Barclays
Koichi Mamegano	BofA Global Research
Hidemaru Yamaguchi	Citigroup Inc